GHRP-6

GHRP-6 is a first-generation growth hormone-releasing hexapeptide that potently drives GH release and appetite stimulation; off-label use focuses on boosting GH, increasing hunger, and supporting body composition and recovery, with all five captured community reports rating outcomes positive. Community dosing logs are sparse, but a single clinician source recommends 100 mcg by subcutaneous injection in the morning, run continuously, with labs tracking IGF-1, fasting glucose, HbA1c, prolactin, and cortisol. There is no FDA-approved indication, so all human use is off-label or compounded.

GHRP-6

Research Evidence

Evidence shape

GHRP-6 sits squarely in the animal-only tier. Only one indication is mapped across the entire catalog — preclinical mechanistic research — and the human trial record is completely blank, showing zero registered studies, no completed trials, and no results at all. There are no withdrawn or terminated studies to examine, nothing has advanced to human testing, and any clinical claim about effects in people is entirely unsupported by human trial evidence.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth24 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
12
HighMediumLow

Anecdotal efficacy

Side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

1
UK
2400 mg
$22.85
$0.013/mg
2
HK
100 mg
$50.00
$0.5/mg
3
CN
100 mg
$154.00
$1.54/mg
4
UK
10 mg
$17.50
$1.75/mg
5
JP
10 mg
$18.70
$1.87/mg
6
UK
10 mg
$22.89
$2.29/mg

price offers can be sorted by column

1-6 of 51

Dosing & Protocol

How GHRP-6 is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance · n = 1
Typical dose
100 µg
100 µg
100 µg
Frequency
daily
Timing
unspecified
Route
subQ
Cycle
unspecified

Clinician protocols dose 100 µg daily subQ (1 source).

1 source
Anecdotal
Community-reported real-world use · n = 2
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Community reports indicate GHRP-6 use for GH release and appetite stimulation, with 2 out of 2 reports being positive. Specific dosing information from these anecdotal reports is not available at this time.

Peptide Deep Dive

Peptide Deep Dive is not projected for this peptide yet.

Peptide feedback

0 forum replies

Live community discussion for GHRP-6, shown here in the site layout and continued on the TVR forum.

Add feedback

No peptide feedback yet

Start the peptide feedback thread on the TVR forum.